Literature DB >> 205867

Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides.

A J Blume.   

Abstract

This study shows that nucleotides, as well as ions, regulate the opiate receptors of brain. GMP-P(NH)P and Na(+) reduce the amount of steady-state specific [(3)H]dihydromorphine binding and increase the rate of dissociation of the ligand from the opiate receptor. In contrast, Mn(2+) decreases the rate of ligand dissociation and antagonizes the ability of Na(+) to increase dissociation. The effects of GMP-P(NH)P on steady-state binding and dissociation are not reversed by washing. Only GTP, GDP, ITP, and IMP-P(NH)P, in addition to GMP-P(NH)P, increase the rate of dihydromorphine dissociation. The site of nucleotide action appears to have high affinity: <1 muM GMP-P(NH)P produces half-maximal increases in ligand dissociation. GMP-P(NH)P- and Na(+)-directed increases in dissociation have also been found for the opiate agonists [(3)H]etorphine, [(3)H]Leu-enkephalin, and [(3)H]Met-enkephalin and the opiate antagonist [(3)H]naltrexone. Mn(2+)-directed decreases in dissociation have been found for the agonist [(3)H]-etorphine and the antagonist [(3)H]naltrexone. Although the plasma membrane receptors for a number of other neuro-transmitters and hormones are also regulated by guanine nucleotides, the opiate receptors appear unique because only they show nucleotide regulation of both agonist and antagonist binding.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205867      PMCID: PMC392409          DOI: 10.1073/pnas.75.4.1713

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.

Authors:  P M Lad; A F Welton; M Rodbell
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

2.  Regulation of prostaglandin receptors by prostaglandins and guanine nucleotides in frog erythrocytes.

Authors:  R J Lefkowitz; D Mullikin; C L Wood; T B Gore; C Mukherjee
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

3.  Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells.

Authors:  A Goldstein; B M Cox; W A Klee; M Nirenberg
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

4.  Mode of action of endogenous opiate peptides.

Authors:  W A Klee; M Nirenberg
Journal:  Nature       Date:  1976-10-14       Impact factor: 49.962

5.  The requirement of guanine nucleotides for glucagon stimulation of adenylate cyclase in rat liver plasma membranes.

Authors:  N Kimura; N Nagata
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

6.  Stimulation of catecholamine-sensitive adenylate cyclase by 5'-guanylyl-imidodiphosphate.

Authors:  R J Lefkowitz
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

7.  Morphine-like peptides, leucine enkephalin and methionine enkephalin: interactions with the opiate receptor.

Authors:  R Simantov; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

8.  Temperature and ionic influences on opiate receptor binding.

Authors:  R Simantov; A M Snowman; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

9.  Selective enhancement of [3H]opiate agonist binding by divalent cations.

Authors:  G W Pasternak; A M Snowman; S H Snyder
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

10.  5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells.

Authors:  C Londos; Y Salomon; M C Lin; J P Harwood; M Schramm; J Wolff; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  31 in total

1.  Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding.

Authors:  H Glossmann; P Presek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.

Authors:  F Niroomand; R A Mura; L Piacentini; W Kübler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  Reconstitution of high-affinity opioid agonist binding in brain membranes.

Authors:  A E Remmers; F Medzihradsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP.

Authors:  A J Blume; D Lichtshtein; G Boone
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

8.  Solubilization of a mammalian beta-adrenergic receptor.

Authors:  J Kleinstein; H Glossmann; L Braun; C Konrad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

9.  Binding and structure-activity-relation of benzo[f]isoquinoline- and norcodeinone-derivatives at mu-opioid receptors in the rat cerebral cortex.

Authors:  M Freissmuth; W Beindl; M Kratzel
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.